Cerebrospinal Fluid Levels of Chromogranin A in Parkinson's Disease and Multiple System Atrophy.

Michaela KaiserovaMonika ChudackovaKaterina MensikovaMiroslav VastikSandra KurcovaHana Prikrylova VranovaDavid StejskalPetr Kanovsky

Published in: Brain sciences (2021)

We observed a tendency toward lower CSF CgA levels in both PD and MSA compared to the control group; however, the difference reached statistical significance only in MSA. Based on these results, CgA may have potential as a biomarker in PD and MSA, but further studies on larger numbers of patients are needed to draw conclusions.

Keyphrases

cerebrospinal fluid
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
risk assessment
human health
patient reported